These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12121138)
1. Synthesis of peptide-oligonucleotide conjugates with single and multiple peptides attached to 2'-aldehydes through thiazolidine, oxime, and hydrazine linkages. Zatsepin TS; Stetsenko DA; Arzumanov AA; Romanova EA; Gait MJ; Oretskaya TS Bioconjug Chem; 2002; 13(4):822-30. PubMed ID: 12121138 [TBL] [Abstract][Full Text] [Related]
2. New method to prepare peptide-oligonucleotide conjugates through glyoxylic oxime formation. Singh Y; Defrancq E; Dumy P J Org Chem; 2004 Nov; 69(24):8544-6. PubMed ID: 15549841 [TBL] [Abstract][Full Text] [Related]
3. Chemoselective oxime and thiazolidine bond formation: a versatile and efficient route to the preparation of 3'-peptide-oligonucleotide conjugates. Villien M; Defrancq E; Dumy P Nucleosides Nucleotides Nucleic Acids; 2004; 23(10):1657-66. PubMed ID: 15620102 [TBL] [Abstract][Full Text] [Related]
11. New strategy for the synthesis of 3',5'-bifunctionalized oligonucleotide conjugates through sequential formation of chemoselective oxime bonds. Edupuganti OP; Singh Y; Defrancq E; Dumy P Chemistry; 2004 Nov; 10(23):5988-95. PubMed ID: 15497169 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of a new class of HIV-1 inhibitors. Farese-Di Giorgio A; Pairot S; Patino N; Condom R; Di Giorgio C; Aumelas A; Aubertin AM; Guedj R Nucleosides Nucleotides; 1999 Feb; 18(2):263-75. PubMed ID: 10067276 [TBL] [Abstract][Full Text] [Related]
13. Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production. Kaushik N; Basu A; Palumbo P; Myers RL; Pandey VN J Virol; 2002 Apr; 76(8):3881-91. PubMed ID: 11907228 [TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967 [TBL] [Abstract][Full Text] [Related]
15. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription. Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777 [TBL] [Abstract][Full Text] [Related]
16. 4-(2-aminooxyethoxy)-2-(ethylureido)quinoline-oligonucleotide conjugates: synthesis, binding interactions, and derivatization with peptides. Hamma T; Miller PS Bioconjug Chem; 2003; 14(2):320-30. PubMed ID: 12643742 [TBL] [Abstract][Full Text] [Related]
17. A novel heterobifunctional linker for facile access to bioconjugates. Singh Y; Spinelli N; Defrancq E; Dumy P Org Biomol Chem; 2006 Apr; 4(7):1413-9. PubMed ID: 16557331 [TBL] [Abstract][Full Text] [Related]
18. Diels-Alder cycloadditions in water for the straightforward preparation of peptide-oligonucleotide conjugates. Marchán V; Ortega S; Pulido D; Pedroso E; Grandas A Nucleic Acids Res; 2006 Feb; 34(3):e24. PubMed ID: 16478710 [TBL] [Abstract][Full Text] [Related]